Compare ICFI & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICFI | SLP |
|---|---|---|
| Founded | 1969 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 293.5M |
| IPO Year | 2006 | 1997 |
| Metric | ICFI | SLP |
|---|---|---|
| Price | $76.24 | $12.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $99.25 | $25.00 |
| AVG Volume (30 Days) | 137.6K | ★ 392.2K |
| Earning Date | 02-26-2026 | 01-08-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.30 | N/A |
| Revenue | ★ $1,925,502,000.00 | $78,676,000.00 |
| Revenue This Year | N/A | $2.64 |
| Revenue Next Year | $2.52 | $6.01 |
| P/E Ratio | $14.26 | ★ N/A |
| Revenue Growth | N/A | ★ 5.70 |
| 52 Week Low | $72.03 | $12.00 |
| 52 Week High | $114.35 | $37.67 |
| Indicator | ICFI | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 25.41 | 23.34 |
| Support Level | $75.13 | $12.00 |
| Resistance Level | $87.84 | $14.78 |
| Average True Range (ATR) | 3.57 | 1.02 |
| MACD | -2.16 | -0.53 |
| Stochastic Oscillator | 2.07 | 6.29 |
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.